7th HIV Cured With Normal Stem Cells

Image: HIV virus particles budding from an infected T cell. Scientists continue to explore new treatment pathways for HIV/AIDS. [Image source: New Scientist]

A Breakthrough in HIV Treatment: Seventh Person Cured Without Resistant Stem Cells

In a remarkable development that could reshape the future of HIV treatment, a man has become the seventh person globally to be cured of HIV. What makes this case particularly groundbreaking is that the cure was achieved using stem cells that weren’t genetically resistant to the virus – challenging long-held assumptions about how HIV can be eliminated from the human body.

An Unexpected Medical Milestone

The patient, known as the “Düsseldorf patient” and identified as Marc Franke, received a stem cell transplant in 2013 to treat acute myeloid leukemia, a form of blood cancer. What doctors didn’t expect was that this treatment would also eliminate his HIV infection. After stopping antiretroviral therapy in November 2018, Franke has remained HIV-free, marking a significant departure from previous successful HIV cures.

“The belief was that using these HIV-resistant stem cells was essential,” explains Dr. Gaebler, a researcher involved in the case. This assumption was based on previous successful treatments where patients received stem cells from donors carrying the rare CCR5-delta-32 mutation, which makes immune cells naturally resistant to HIV.

How Stem Cell Transplants Cure HIV

Traditional Approach: Resistant Cells

The first documented case of HIV cure through stem cell transplant was Timothy Ray Brown, known as the “Berlin patient,” in 2008. Brown had HIV and developed acute myeloid leukemia. His doctors discovered that his donor carried a rare genetic mutation called CCR5-delta-32, which affects the CCR5 receptor that HIV uses to enter immune cells. People with two copies of this mutation are naturally resistant to HIV infection.

This approach was successfully replicated with the “London patient” Adam Castillejo in 2019 and several others. The procedure involves:

Destroying the patient’s cancer-afflicted immune system with chemotherapy
Replacing it with stem cells from a donor with the CCR5-delta-32 mutation
The new immune system lacks the CCR5 receptors HIV needs to infect cells

Unexpected Mechanism: The Graft-versus-Reservoir Response

However, the Düsseldorf patient’s case is different. His donor had only one copy of the CCR5-delta-32 mutation, not the two copies typically required for HIV resistance. So how did he achieve remission?

The answer may lie in what scientists call the “graft-versus-reservoir response.” This mechanism involves the new immune system recognizing and eliminating remaining HIV reservoirs – dormant virus hiding in long-lived immune cells. This phenomenon is similar to the “graft-versus-leukemia” response that helps fight cancer after stem cell transplants.

As research published in medical journals explains, “This mechanism facilitates graft-versus-reservoir (GVR) effects in HIV infection, which resembles the effect of graft-versus-leukemia (GVL) in cancer.” Essentially, the new immune cells from the donor recognize the patient’s HIV-infected cells as foreign and eliminate them.

Significance Beyond the Individual Case

Expanding Possibilities for Treatment

This case represents only the second documented instance of HIV cure without using resistant stem cells, following the “Geneva patient” case. The significance extends far beyond this individual’s remarkable recovery:

Challenging Assumptions: It demonstrates that HIV cure might be possible without the rare CCR5 mutation
Broadening Donor Pool: If confirmed, this approach could potentially expand treatment options since finding donors with the CCR5 mutation is extremely difficult
New Research Pathways: It opens doors to exploring the graft-versus-reservoir mechanism as a therapeutic approach

As the World Health Organization notes, HIV remains a significant global health challenge, with millions of people living with the virus worldwide. While antiretroviral therapy can effectively suppress the virus, a true cure has remained elusive.

Understanding the Limitations

Despite this promising development, it’s crucial to note that stem cell transplants are not a practical solution for most people living with HIV. These procedures are:

Highly toxic and dangerous
Typically only performed on cancer patients with no other treatment options
Associated with significant mortality risk
Require finding a compatible donor

As Dr. Jensen of Düsseldorf University Hospital explains, “Stem cell transplants not a scalable treatment.” The goal of HIV cure research, according to WHO guidelines, is to develop safe, effective, and scalable therapies that could reach the global HIV population.

The Future of HIV Treatment Research

While stem cell transplants remain impractical for widespread use, this case provides valuable insights for HIV researchers. Understanding how the graft-versus-reservoir mechanism works could lead to the development of less invasive treatments that harness the same principles.

Current research is exploring several promising avenues:

Gene therapy: Engineering a patient’s own cells to lack CCR5 receptors
Therapeutic vaccines: Training the immune system to better recognize and eliminate HIV reservoirs
Latency-reversing agents: Drugs that force HIV out of hiding so it can be targeted by the immune system

The National Institutes of Health continues to fund research into these approaches, with the ultimate goal of developing treatments that are both effective and accessible to all who need them.

Conclusion: A Step Forward in a Long Journey

The case of the Düsseldorf patient represents a significant milestone in HIV research, not because it provides a new treatment option, but because it expands our understanding of how HIV might be eliminated from the body. By demonstrating that cure is possible without the traditionally required genetic resistance, this case opens new theoretical pathways for researchers to explore.

While we’re still far from a broadly applicable HIV cure, each case like this contributes valuable knowledge to the field. As the medical community continues to build on these insights, the hope remains that one day, HIV could join polio and smallpox in the history books as a disease humanity has overcome.

For now, this breakthrough serves as both a testament to the power of medical science and a reminder that even in well-understood fields, unexpected discoveries can still challenge our assumptions and light the way forward.